White & Case has advised Pelion on a EUR 25 million equity investment from the European Bank for Reconstruction and Development through a capital increase. Dentons advised the EBRD.
Pelion is a Polish company providing services across the pharmaceutical distribution market to individual patients, pharmacies, hospitals, and manufacturers.
According to White & Case, “as a result of the investment, the EBRD will become a minority shareholder holding 4.35% of the shares in Pelion. The EBRD’s investment will provide support for Pelion to further strengthen its position in the pharmaceutical market in Poland and Europe, as well as explore and develop new business areas.”
The White & Case team included Warsaw-based Partner Marcin Studniarek, Of Counsel Aneta Hajska, and Associate Damian Lubocki.
The Dentons team included Warsaw-based Partners Jakub Celinski and Marceli Kasperkiewicz and Senior Associate Paulina Galewska and Prague-based Partner Chris Watkinson and Associate Petr Mueller.
